Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus.

Abdelnabi M, Nhat Pham H, Ibrahim R, Allam M, Pathangey G, Choon Tan M, Lee K, Fortuin FD, Alsidawi S, Ayoub C, Alkhouli M, Arsanjani R.

Open source

DOI: 10.2459/jcm.0000000000001936
Published: 2026-08-27
Container: J Cardiovasc Med (Hagerstown)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2459/jcm.0000000000001936,
  title = {Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus.},
  author = {Abdelnabi M and  Nhat Pham H and  Ibrahim R and  Allam M and  Pathangey G and  Choon Tan M and  Lee K and  Fortuin FD and  Alsidawi S and  Ayoub C and  Alkhouli M and  Arsanjani R.},
  year = {2026},
  journal = {J Cardiovasc Med (Hagerstown)},
  doi = {10.2459/jcm.0000000000001936},
  url = {https://doi.org/10.2459/jcm.0000000000001936}
}

RIS

TY  - JOUR
TI  - Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus.
AU  - Abdelnabi M
AU  -  Nhat Pham H
AU  -  Ibrahim R
AU  -  Allam M
AU  -  Pathangey G
AU  -  Choon Tan M
AU  -  Lee K
AU  -  Fortuin FD
AU  -  Alsidawi S
AU  -  Ayoub C
AU  -  Alkhouli M
AU  -  Arsanjani R.
PY  - 2026
JO  - J Cardiovasc Med (Hagerstown)
DO  - 10.2459/jcm.0000000000001936
UR  - https://doi.org/10.2459/jcm.0000000000001936
ER  -

APA

M, A., H, N. P., R, I., M, A., G, P., M, C. T., K, L., FD, F., S, A., C, A., M, A., & R., A. (2026). Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus.. J Cardiovasc Med (Hagerstown). https://doi.org/10.2459/jcm.0000000000001936

Source records

europe-pmc · retrieved 2026-09-26T12:15:13.086Z